Search our Available Technologies
Biologics
Mining microbial genomes for biologically active compounds
Most microbes of importance to human and environmental health are...
MORE >Novel AnnexinA1 tripeptide (ANXA1sp) improves acute kidney injury after deep hypothermic circulatory arrest
Value Proposition Heart disease is the leading cause of death...
MORE >Novel cardioprotective tripeptide for global myocardial ischemia and reperfusion injury exacerbated by acute hyperglycemia
Value Proposition Heart disease is the leading cause of death...
MORE >A universal antidote for aptamer therapeutics
Value Proposition With an ever increasing number of people taking...
MORE >A therapeutic formulation for preventing posttraumatic osteoarthritis after joint injuries
Value Proposition Osteoarthritis (OA) is an affliction of the joints...
MORE >Dual agonist proteins for the treatment of metabolic disease
Value proposition Diabetes affects 30 million people in the United...
MORE >A fully human EGFRvIII-targeted bispecific antibody engaging T cells for antitumor therapy
Value Proposition The most common malignant brain tumor, glioblastoma multiforme...
MORE >Increasing the half-life of therapeutic proteins and peptides using elastomeric-like polypeptides with environmental sensitivity
Value Proposition Since insulin was used as the first therapeutic...
MORE >Lowering ApoE to improve age-related bone fracture healing
Value Proposition Bone fractures occur in 50% of the population,...
MORE >Enhanced delivery of drugs and other compounds to the brain and other tissues
Value Proposition For many drugs and diagnostic agents, no readily...
MORE >